Who invested in Vivace Therapeutics

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$75Mraised across 2 rounds since 2017, from 2 sources

$40MRound$35MSeries D

Latest round: Series D, $35MMar 2025
Biggest round: $40MRound · Jun 2017
Investors: 7

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20172019202120232025

$40MRound$35MSeries D

First round: Round, $40M
Biggest round: $40M
Between rounds: 7.7 years

The rounds

Mar 2025
Series D$35M3 new1 returning
Source recordedSEC filing: $17M sold, first sale Feb 2025
Jun 2017
Round$40M4 new
- Canaan
- Mission Bay Capital
- Wuxi Capital
- Cenova Capital/ Sequoia
Reported by FinSMEsSEC filing: $8.0M sold, first sale May 2017

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Round2017Series D2025

Canaan

Sequoia Capital

RA Capital Management

Mission BioCapital

Mission Bay CapitalWuxi CapitalCenova Capital/ Sequoia

Everyone who backed them

CanaanVC firm2rounds

Sequoia CapitalVC firm1round

RA Capital ManagementPrivate equity1round

Mission BioCapitalVC firm1round

Mission Bay CapitalVC firm1round

Wuxi CapitalPrivate equity1round

Cenova Capital/ Sequoiano record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Vivace Therapeutics

Who invested in Vivace Therapeutics?

Vivace Therapeutics's investors include Canaan, Sequoia Capital, RA Capital Management, Mission BioCapital and Mission Bay Capital, and 2 more on record.